Suchergebnisse - Jingfang Ju

Challenges and opportunities in microRNA-based cancer therapeutics von Jingfang Ju

Volltext

Development of novel 5-FU modified siRNA against BCL-2 with enhanced efficacy and vehicle-free cellular uptake von Andrew Fesler, Ga-Ram Hwang, Jingfang Ju

Volltext

The Sensitization of Triple-Negative Breast Cancers to Poly ADP Ribose Polymerase Inhibition Independent of BRCA1/2 Mutation Status by Chemically Modified microRNA-489 von Young Hwa Soung, Jingfang Ju, Jun Chung

Volltext

Prognostic significance of miR-205 in endometrial cancer. von Mihriban Karaayvaz, Cecilia Zhang, Sharon Liang, Kenneth R Shroyer, Jingfang Ju

Volltext

Reduction of Orc6 expression sensitizes human colon cancer cells to 5-fluorouracil and cisplatin. von Elaine J Gavin, Bo Song, Yuan Wang, Yaguang Xi, Jingfang Ju

Volltext

Arrestin Domain Containing 3 Reverses Epithelial to Mesenchymal Transition and Chemo-Resistance of TNBC Cells by Up-Regulating Expression of miR-200b von Young Hwa Soung, Heesung Chung, Cecilia Yan, Jingfang Ju, Jun Chung

Volltext

Development of a 5-FU modified miR-129 mimic as a therapeutic for non-small cell lung cancer von Ga-Ram Hwang, John G. Yuen, Andrew Fesler, Hannah Farley, John D. Haley, Jingfang Ju

Volltext

Development of gemcitabine-modified miRNA mimics as cancer therapeutics for pancreatic ductal adenocarcinoma von John G. Yuen, Ga-Ram Hwang, Andrew Fesler, Erick Intriago, Amartya Pal, Anushka Ojha, Jingfang Ju

Volltext